Experience of Transcatheter Arterial Embolization for Advanced Gastric Cancer with Bleeding

Abstract

Background: Interventional transcatheter arterial embololization (TAE) is one of the treatment options for the treatment of gastric cancer bleeding when endoscopic treatments fail. The clinical usefulness of TAE for bleeding associated with advanced gastric cancer was retrospectively evaluated.

Methods: Nine patients with bleeding from advanced gastric cancer underwent TAE between January 2012 and December 2015 were enrolled in this study. If the patient was discharged from hospital without transfusion for thirty days after TAE, we defined the procedure as clinical success. We retrospectively reviewed the clinical success rate and the clinical outcome.

Results: The overall clinical success rate was 56% (5/9). One case of Grade 3 splenic infarction, one case of Grade 3 pylorus stenosis, three cases of Grade 2 abdominal pain were found. In five cases of successful TAE, three patients were performed chemotherapy and one patient underwent gastrectomy. The overall survival was 8.1 months and 1.4 months in successful and unsuccessful cases, respectively.

Conclusions: In patients with bleeding from advanced gastric cancer, TAE was useful because the clinical success rate of TAE was 56% and patients were able to be discharged and undergo chemotherapy if TAE was successful.